Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic ovarian syndrome

JOURNAL TITLE: Journal of South Asian Federation of Obstetrics and Gynaecology

Author
1. Usha Gupta
2. Rashmi Ahuja
3. Priyanka Sharma
4. Raina Chawla
ISSN
0974-8938
DOI
10.5005/jp-journals-10006-1674
Volume
11
Issue
3
Publishing Year
2019
Pages
6
Author Affiliations
    1. Department of Obstetrics and Gynaecology, ESIC Medical College and Hospital, Faridabad, Haryana, India
    1. Kasturba Medical College and Hospitals, Mangaluru, Karnataka, India
    2. Lady Hardinge Medical College, New Delhi, India
    1. Department of Obstetrics and Gynaecology, ESIC Medical College and Hospital, Faridabad, Haryana, India
    1. Lady Hardinge Medical College and SSK Hospital, New Delhi, India
    2. Lady Hardinge Medical College and SSK Hospital, New Delhi
    3. Lady Hardinge Medical College and Associated Smt SK Hospital, New Delhi
    4. Lady Hardinge Medical College, New Delhi
    5. Maulana Azad Medical College, New Delhi, Nodal Corporate Resource for Clinical Pharmacology and Medication Management, Fortis Hospital, Noida, Uttar Pradesh, India
    6. ESI, Faridabad Medical College, Faridabad Haryana
    7. Maulana Azad Medical College, New Delhi, India
  • Article keywords
    Anti-Müllerian hormone, Hyperandrogenemia, Polycystic ovarian syndrome

    Abstract

    Aim: To examine the association of serum anti-Müllerian hormone (AMH) levels with biochemical derangement and sonographic appearance in PCOS women and to examine its role as a possible marker for diagnosis and prognosis of polycystic ovarian syndrome (PCOS). Materials and methods: This case-control study was conducted on patients attending the Gynecology OPD at ESIC Medical College and Hospital, Faridabad, Haryana from March 2017 to September 2017. 45 PCOS women and controls between 18 years and 45 years were recruited. Relevant clinical, biochemical, and sonographic data were collected. Linear regression was used to study the association between biochemical and sonographic variables and PCOS. Receiver-operating characteristic (ROC) curve analysis was performed for AMH, LH/FSH ratio, antral follicle count (AFC), and mean ovarian volume. The AMH cut-off value was determined for the prediction of PCOS. Results: Mean AMH levels were significantly higher in the PCOS group (5.9 v/s 2.36 ng/mL). In PCOS women, AMH levels positively correlated with AFC, mean ovarian volume, as well as androstenedione and testosterone levels. In controls, a significant positive correlation was found with serum testosterone and mean ovarian volume. An AMH had greater diagnostic potential for detecting PCOS compared to AFC, mean ovarian volume, and LH/FSH ratio. A threshold AMH value of 3.98 ng/mL had a sensitivity of 82.2% and a specificity of 93.3% for diagnosing PCOS. Conclusion: Serum AMH levels correlate well with hyperandrogenemia and sonographic features of PCOS and could be used as a marker for hormonal dysfunction and disease severity. Clinical significance: An AMH is a promising marker that could improve the diagnosis of PCOS and also help in establishing disease severity.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved